of interest to distinguish the spasm-related atherosclerosis from the unrelated lesion. In the present study, the coronary sites with or without focal coronary spasm were studied by IVUS to investigate the morphologic appearance of the vasospastic atherosclerosis.
Methods

Subjects
A total of 51 patients who underwent the ergonovine or acetylcholine provocative test were entered the present study. Although not a consecutive series, the study group represented all recruitable patients who gave written informed consent. All patients have atypical chest pain at rest and/or on exertion. Sixteen patients had a history of previous myocardial infarction, but none of them had undergone interventional procedures, other than thrombolytic therapy, and they required coronary angiography for the diagnosis of their chest pain. All antianginal drugs except sublingual nitroglycerin were discontinued at least 12 h prior to catheterization. Of the patients enrolled, the IVUS examination could be completed in 45 (35 men, 10 women; mean age, 58±10 years).
Catheterization Procedure
The study protocol was approved by the Ethical Review Committee. After administration of 3,000 U of heparin, coronary angiography was performed by the standard Judkins technique using a biplane cineangiography system. The absence of luminal narrowing >50% was confirmed by injection of contrast medium into the left and right coronary arteries. Subsequently, 1 ml of ergonovine maleate solution (0.01 mg) was injected into either the left or the Circulation Journal Vol.67, December 2003 right main coronary artery through the catheter and was administered every 3 min until there was either spasm or the maximal dose of 0.04 mg had been given. 13 In the acetylcholine provocation test, under right atrial pacing, 100 g was injected into the left coronary artery and 50 g into the right coronary artery. A standard 12-lead ECG was carefully monitored and recorded every 30 s. Focal coronary spasm was defined as localized transient vessel narrowing associated with myocardial ischemia including ST elevation >0.1 mV on the ECG. When chest pain associated with ST elevation was experienced, angiography was immediately performed, and subsequently, nitroglycerin (0.25 mg) was injected into the coronary artery through the catheter to relieve the spasm.
IVUS Examination
In the present study we used a mechanically rotating monorail ultrasound catheter with a 30 MHz transducer (3.5Fr, Sonicath or 3.2Fr, Ultracross, Boston Scientific Corporation) for the coronary observation. A 6 or 7Fr guiding catheter was used for insertion of the IVUS catheter. After additional administration of heparin (5,000 U), a 0.014-inch angioplasty guidewire was advanced through the ultrasound catheter, and fluoroscopically guided into the distal coronary artery. The ultrasound imaging catheter was then advanced over the guidewire into the vessel. To observe the boundary between the coronary lumen and the intimal leading edge, the optimal gain setting was performed by adjusting the transmitting ultrasound power or the receiving gain.
In patients with focal coronary spasm, the IVUS probe was initially placed proximal to the site of spasm and was then carefully advanced to the site where spasm had occurred. 8 Injection of a small amount of contrast medium often assisted recognition of the intimal leading edge of the site examined 14 and also provided a method of insuring that insertion of the ultrasound catheter probe had not itself induced coronary spasm. After observing the site distal to the spasm, the imaging probe was carefully pulled back through the spastic site, again confirming the presence or absence of any lesions. In patients without focal coronary spasm, the ultrasound catheter was advanced into the coronary artery as distally as possible, and then was carefully pulled back to continuously observe the wall morphology. When atherosclerotic lesions that had not been detected by angiography were observed, careful IVUS examination was performed by referring to the side branches and/or wall calcification as landmarks. All the images were recorded on S-VHS videotape for subsequent analysis.
IVUS Image Analysis
The frames of the cardiac cycle that showed the largest size of the lumen with optimal delineation of the bloodintimal border were selected for analysis. Measurements were performed at the sites where the vessel wall was maximally thickened. We measured the following indices of the atherosclerotic lesions. Percent plaque area was determined by the following formula: {(EEM -LA)/EEM} × 100, where LA was lumen area that was measured by tracing the boundary between the vessel lumen and the intimal leading edge, and EEM was the total area that was measured by tracing the leading edge of the second bright echo. 15 Hangartner et al suggested that circumferential plaque distribution might be a determinant for vasoreactivity in coronary artery disease 16 and so we measured the arc of the disease to quantitatively evaluate circumferential disease distribution (Fig 1) . Under these conditions, we considered disease thickness >0.5 mm to be significant and measured the angle between 2 lines drawn from the lumen center. 17 Plaque echo intensity was defined as high or low when the intensity was higher or not higher than that of the adventitia. The presence of calcified lesions was defined as a high intensity echo image with acoustic shadowing. 18 Measurements were performed at end-diastole and measured values represent the average of 3 consecutive beats.
Intraobserver and Interobserver Variabilities
Intraobsever and interobserver variabilities for measurements of % plaque area and plaque arc were determined by 2 independent observers and by 1 observer at 2 separate times. Also, the reproducibility of IVUS image analysis was examined the same way. These data were used in the assessment of inter-and intraobserver variabilities.
Statistics
All data are expressed as mean ± SD. We used unpaired Students t-test to compare continuous variables and the chi-square test for categorical variables. We considered differences significant at p<0.05.
Results
Patient Data are summarized in Table 1 .
Provocation of Focal Coronary Spasm
Of the 45 patients who underwent the complete exami- nation, significant focal coronary spasm was provoked in 23 (mean age, 56 years old). The examined vessel in this patient group was the left anterior descending artery in 14 patients, right coronary artery in 8 and left circumflex artery in 1. Focal spasm was not provoked in the remaining 22 patients, although diffuse coronary narrowing without signs of myocardial ischemia was observed (left anterior descending artery in 17 patients, right coronary artery in 5).
In the 23 patients with focal spasm, atherosclerotic disease, characterized by the presence of intimal thickening, was observed by IVUS at all 23 sites where spasm had been provoked. In contrast, in the 22 patients without focal spasm, atherosclerosis was found by IVUS in 18 sites from 17 patients; in the remaining 5 patients, significant lesions were not detected by IVUS or angiography. 8 
Plaque Characteristics
In the 23 coronary sites with focal spasm, the total vessel area and lumen area was 15.6±4.0 mm 2 and 8.0±2.3 mm 2 , respectively. Thus, the calculated percent plaque area was 47±10%. In the 18 diseased sites without spasm, the total vessel area and lumen area was 16.2±4.8 mm 2 (NS) and 9.8±3.3 mm 2 (NS), respectively, and the calculated percent plaque area was 39±15% (NS). The arc of the disease at the sites with focal spasm was 298±71°, which was greater than that at the sites without spasm (249±83°) without statistical significance (Table 1) .
Low echo intensity was observed in 20 of the 23 lesions with coronary spasm and in 8 of the 18 lesions without spasm (NS). Calcified lesions were observed at 5 of the 23 coronary sites with spasm. In contrast, 18 diseased sites without spasm contained 12 calcified lesions (Figs 2,3 , p<0.05). Thus, the regional plaque associated with focal coronary spasm is mainly a relatively low-echo intensity lesion without calcification.
Discussion
We previously reported that IVUS detected atherosclerotic lesions at the sites of focal or diffuse coronary spasm, even in the absence of angiographically confirmed disease. 8, 19 However, in the clinical setting these angiographically occult atherosclerotic lesions can also be present in coronary sites where spasm is not provoked. 20 Therefore, it is of clinical interest to examine the morphologic features of plaque associated with and without focal coronary spasm. A preliminary result regarding the angiographic appearance of the plaque with focal coronary spasm has been reported by Tousoulis et al, who demonstrated that there was no distinct evidence for a morphological difference in the preexisting atherosclerotic disease. 21 However, angiography can misinterpret plaque morphology. 18 
Advantage of the Present Study
In the present study, IVUS was used to evaluate disease morphology and we also examined the plaque characteristics by determining the tissue echo intensity associated with or without calcification. We found that calcified lesions were less frequent at the sites with focal coronary spasm than at the sites without spasm, although the echo intensity was not different between the 2 patient groups. If a calcified lesion represents plaque aging, one might speculate that the early stage of an atherosclerotic lesion is closely related to the occurrence of focal coronary spasm. This finding coincides with the histologic observation that at the site of spasm the plaque mainly consists of neointimal proliferation rather than fibrous tissue. 22 In the clinical setting, coronary spasm is most common in patients around the age of 50 years, after which the incidence decreases with aging. 3, 23 However, because atherosclerotic lesions are frequently observed in the angiographically normal coronary artery, the observations in the present study may not be specific to VA.
The present findings support the experimental evidence that the early stage of atherosclerosis plays a pivotal role in the occurrence of focal coronary spasm. Shimokawa et al speculated that during the development of the atherosclerotic lesion, chemical mediators such as cytokines could be the possible messenger for the induction of coronary spasm. 24 Depressed production of nitric oxide seems to be another mechanism of spasm in the presence of atherosclerotic lesions, 25 even though endothelial function is preserved during vasospasm. 10, 26 As for the circumferential distribution of the atherosclerotic lesions, the arc of the disease was not different between the 2 patient groups. This finding is similar to that of Tousoulis et al, 21 who demonstrated that both eccentric and concentric lesions had the same potential to induce coronary spasm, although vessel spasmogenicity may be lost in the presence of a circumferential atherosclerotic lesion. 16 Whether the media is involved in the atherosclerosis seems to be a determinant factor for vessel spasmogenicity, irrespective of circumferential disease distribution. 27 
Clinical Implications
First, the finding that non-calcified atherosclerotic lesions seems closely related to the occurrence of focal coronary spasm suggests a therapeutic implication for occult atherosclerotic lesions; that is, patients with documented vasospasm should be treated with either calcium channel blockers or nitrates, 23 but should these drugs be given to patients with atypical chest pain? In those cases, demonstration of non-calcified atherosclerotic disease by IVUS may assist in determining the indication for treatment.
Second, risk factors such as smoking and hypercholesterolemia should be strictly controlled when occult atherosclerosis is detected by IVUS, because coronary spasm is known to accelerate the progression of the atherosclerosis [28] [29] [30] and preexisting atherosclerosis is a most important determinant factor for long-term prognosis. 23 During follow-up of patients with coronary spasm, we sometime find there is spontaneous diminution of the angina attacks, which may be explained by the present finding that as the atherosclerotic lesion matures, there is a resultant loss of vasoreactivity. 31 
Study Limitations
One of the major limitations of the present study was the criteria of the control patients, defined as a negative spasm provocation test. Even if coronary spasm was not provoked, we could not completely rule out vasospastic angina. How- ever, clinically these patients did not show any signs of coronary spasm and it is reasonable to consider them as the control group.
We demonstrated that a non-calcified atherosclerotic lesion was frequently present at the sites of focal coronary spasm, but we only analyzed the difference in the echo-density and the presence of calcified lesions, and the histologic difference of occult disease associated with spasm is still unclear. Hiro et al showed that simple analysis of echo density could result in misinterpretation of tissue composition, other than the presence of calcification, 32 which may explain why simple comparison of echo density could not distinguish spasm-related from spasm-unrelated atherosclerotic lesions. Under these conditions, the presence of calcification could be a landmark for comparison, although this method is unlikely to be established. Ultrasound tissue characterization 33 or elastography 34 may demonstrate the difference in plaque composition at sites with or without coronary spasm.
Conclusions
We demonstrated that focal coronary spasm is related to the presence of atherosclerosis without calcification, irrespective of plaque distribution. This suggests that the early stage of atherosclerosis is closely related to the occurrence of focal coronary spasm in the clinical setting, although further study should be done to in vivo determine plaque composition.
